Literature DB >> 14693167

Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.

Andrew J Makin1, Natali A Y Chung, Stanley H Silverman, Gregory Y H Lip.   

Abstract

Peripheral artery disease (PAD) and intermittent claudication are common in men aged over 55 years. Once the diagnosis has been made, very few patients suffer from a deterioration of the disease. Those that do deteriorate tend to do so due to thrombosis of an affected artery. It is apparent that the disruption in the vessel wall accounts for some of the cause of the thrombosis but blood constituents also play a role. We hypothesized that levels of soluble P-selectin (sP-sel, a marker of platelet activation), von Willebrand factor (vWf, an index of endothelial damage/dysfunction), tissue factor (TF, a coagulation protein involved in the 'extrinsic' coagulation pathway) and fibrinogen would be abnormally elevated in relation to disease severity and correlated with each other, and related to ethnicity, in a multiethnic population of patients with PAD. To test this hypothesis, we studied 234 patients (80% white, 7% Indo-Asian, 13% Afro-Caribbean) with confirmed PAD [ankle brachial pressure index (ABPI)< or =0.8] and 50 healthy controls. All of the indices studied were increased in patients over controls (p<0.05). None of the indices of the hypercoagulable state were significantly different between the three ethnic groups studied. Patients with ischaemic rest pain were shown to have higher levels of plasma fibrinogen (p<0.001) although none of the other prothrombotic markers were increased in this group. Furthermore, fibrinogen was higher in cases whose ABPI was below the median (<0.52) when compared to those less severely affected, with an inverse correlation between fibrinogen and ABPI (Spearman, r=-0.178, p=0.009). In conclusion, we found a prothrombotic state in patients with PAD with increased levels of markers of endothelial damage/dysfunction, platelet activation and thrombosis, which may contribute to the pathogenesis of this condition. However, disease severity was only related to plasma fibrinogen levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14693167     DOI: 10.1016/j.thromres.2003.09.012

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of inclacumab in healthy Japanese and Caucasian subjects.

Authors:  Mary Morrison; Guiseppe Palermo; Christophe Schmitt
Journal:  Eur J Clin Pharmacol       Date:  2015-09-12       Impact factor: 2.953

Review 2.  Disparities in vascular surgery: is it biology or environment?

Authors:  Louis L Nguyen; Antonia J Henry
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

Review 3.  Biomarkers and Genetics in Peripheral Artery Disease.

Authors:  Surovi Hazarika; Brian H Annex
Journal:  Clin Chem       Date:  2016-11-21       Impact factor: 8.327

Review 4.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

5.  APC-PCI complex levels for screening of AAA in patients with peripheral atherosclerosis.

Authors:  Moncef Zarrouk; Kave Keshavarz; Bengt Lindblad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 6.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

7.  Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis.

Authors:  Chiz-Tzung Chang; Ming-Yi Shen; An-Sean Lee; Chun-Cheng Wang; Wei-Yu Chen; Chia-Ming Chang; Kuan-Cheng Chang; Nicole Stancel; Chu-Huang Chen
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.